GENOXAL INYECTABLE for Haematological malignancy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 49 adverse event reports in the FDA FAERS database where GENOXAL INYECTABLE was used for Haematological malignancy.
Most Reported Side Effects for GENOXAL INYECTABLE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Graft versus host disease | 43 | 45.7% | 3 | 0 |
| Recurrent cancer | 13 | 13.8% | 13 | 0 |
| Disease progression | 12 | 12.8% | 7 | 0 |
| Death | 11 | 11.7% | 11 | 0 |
| Disease recurrence | 7 | 7.5% | 0 | 0 |
Other Indications for GENOXAL INYECTABLE
Other Drugs Used for Haematological malignancy
RITUXIMAB (144)
CYCLOPHOSPHAMIDE (97)
FLUDARABINE (93)
BUSULFAN (80)
LENALIDOMIDE (71)
IBRUTINIB (62)
DOXORUBICIN (61)
BEVACIZUMAB (55)
MYCOPHENOLATE (49)
NIVOLUMAB (49)